Oral Formulation Of Fludara® Approved In Japan
Mon, 29 Jan 2007 08:00 AM EST
... Bayer Schering Pharma AG announced today that the oral formulation of Fludara® for low-grade non-Hodgkin's Lymphoma and mantle cell lymphoma has received marketing approval in Japan. This new formulation provides a new avenue for simpler and easier outpatient chemotherapy to improve patients' quality of life, as well as that of their families. [click link for full article] ...
Related Topics
- Bexarotene Oral
- Oral Cancer
- Oral Health
- Japan
- U.S.- Japan Cooperative Medical Science Program: Sixth Five Year Report
- Amoxicillin Oral Suspension
- Zidovudine Oral Syrup
- Bismuth Subsalicylate Oral Liquid
- Exelon
- Sumatriptan Oral
- Ergocalciferol, Vitamin D2 Oral Solution
- Stavudine Oral Solution
- Metronidazole Oral
- Erythromycin Oral Suspension
- Fluconazole Oral
- Terbinafine Oral
- Hepatitis B Vaccine
- Methadone Oral
- Mesoridazine Oral Concentrate
- Pseudoephedrine and Hydrocodone

Not Signed In -


